| Property | Details |
|---|---|
| Protein Name | Vesicle transport through interaction with t-SNAREs homolog 1B |
| Gene Name | VTI1B |
| UniProt ID | Q9UEU0 |
| Organism | Homo sapiens (Human) |
| Amino Acid Length | 232 |
| Transmembrane Domains | 1 |
| Key Domains | Qb-SNARE motif |
| Sequence Motif | MASSAASSEHFEKLHE... (truncated; full sequence available in UniProt) |
This protein localizes to the Golgi complex, endosomes, lysosomes, and secretory vesicles .
VTI1B facilitates membrane fusion events through SNARE complex formation:
Autophagy: Partners with syntaxin 7 (STX7), syntaxin 8 (STX8), and VAMP7 to mediate fusion between recycling endosomes and autophagosomes .
Immune Synapse (IS) Dynamics: Recruited to B cell receptor (BCR) activation sites and polarizes to IS interfaces during antigen presentation .
Cytokine Secretion: Essential for post-Golgi trafficking of cytokines in macrophages and secretory lysosome release in cytotoxic lymphocytes .
Resting B Cells: Predominantly associates with Golgi, Rab5⁺ (early endosomes), Rab7⁺ (late endosomes/lysosomes), and Rab11⁺ (recycling endosomes) .
BCR Activation: Enriches at antigen internalization sites and perinuclear compartments within 5–60 minutes of activation .
Immune Synapse: Colocalizes with lysosomes and F-actin foci, suggesting roles in antigen extraction or vesicle recycling .
BCR Signaling: No significant defects in BCR internalization, PLCγ2 phosphorylation, or ERK/AKT signaling pathways .
Antigen Processing: Partial colocalization with internalized antigen vesicles but no impairment in antigen presentation efficiency .
Functional Redundancy: Lack of phenotypic changes in KO models implies compensatory mechanisms by other SNAREs (e.g., VTI1A) .
VTI1B expression is modulated by:
| Modulator | Effect on VTI1B | Source Model |
|---|---|---|
| Bisphenol S/F | ↑ mRNA/protein expression | Human/Rat studies |
| Cyclosporin A | ↓ mRNA expression | Human cell lines |
| Heroin | ↓ mRNA expression | Human neurons |
| Omega-6 fatty acids | ↑ mRNA expression | Human macrophages |
These findings highlight its sensitivity to endocrine disruptors and metabolic signals .
VTI1B forms functional SNARE complexes with:
Syntaxin 8 (STX8): Critical for late endosomal trafficking .
VAMP7/VAMP8: Facilitates lysosomal exocytosis in immune cells .
While direct disease associations remain understudied, VTI1B’s role in autophagy and cytokine secretion suggests potential relevance in:
VTI1B (Vesicle Transport through Interaction with t-SNAREs 1B) is a SNARE protein involved in vesicular trafficking in human cells. Current evidence indicates that VTI1B primarily localizes to the Golgi apparatus and a subset of Rab7+ lysosomal vesicles in resting B cells . As a SNARE protein, it likely participates in membrane fusion events necessary for intracellular transport processes, particularly within the endosomal system. In B lymphocytes, VTI1B appears to be recruited to sites of B cell receptor (BCR) activation, suggesting specific roles in immune cell function .
Research demonstrates that VTI1B concentrates in several distinct subcellular compartments:
| Cellular Compartment | VTI1B Localization | Associated Markers | Observation Methods |
|---|---|---|---|
| Golgi Complex | High | Rab6 | Fluorescence microscopy |
| Lysosomal Vesicles | Partial | Rab7 | Colocalization analysis |
| Cell Periphery | Variable | - | GFP-tagging |
| Immune Synapse | Enriched upon activation | BCR, F-actin | Quantitative imaging |
Research findings show GFP-fused VTI1B predominantly concentrates at the Golgi complex, around the microtubule organizing center (MTOC), as well as in Rab7+ lysosomal vesicles in the cell periphery . Upon B cell activation, partial relocalization to internalized antigen vesicles occurs, particularly in the cell periphery .
Upon BCR activation with surface-bound antigen, VTI1B demonstrates specific recruitment to the immunological synapse (IS). Experimental evidence shows:
GFP-VTI1B significantly polarizes to the IS upon BCR activation using antigen-coated beads or coverslips
Quantitative analysis confirms polarization of Golgi-associated perinuclear VTI1B compartments toward the IS
Mean fluorescence intensity measurements reveal significant enrichment of VTI1B signal at the bead:cell contact area compared to the distal pole
At the IS interface, VTI1B colocalizes with F-actin foci and Rab7+ structures, but shows limited colocalization with Rab11 and Rab6
These findings suggest VTI1B trafficking during IS formation involves cytoskeletal elements and specific endosomal compartments rather than recycling endosomes or Golgi-derived vesicles alone.
Despite clear localization of VTI1B to sites of BCR activation and immune synapses, studies using VTI1B-deficient mouse models revealed no significant functional defects in:
BCR signaling pathway activation
Immunological synapse formation
Processing and presentation of internalized antigen
BCR surface expression levels
This striking lack of phenotype suggests robust compensatory mechanisms, likely involving VTI1B's close homologue VTI1A or other SNARE proteins . This redundancy may represent an evolutionary safeguard for maintaining critical immune cell functions. Researchers investigating VTI1B function should consider:
Simultaneous knockdown of multiple SNARE proteins
Acute inhibition methods to avoid compensatory adaptations
Analysis of subtle phenotypes under specialized conditions
Identification of cell types where redundancy might be less effective
BCR internalization upon activation
IS formation as measured by F-actin spreading area
BCR signaling based on phosphorylated PLCγ2 intensity
Early (pCD19, pSyk) and late (pAKT, pERK1/2) BCR signaling pathway components
These findings present an intriguing paradox: despite specific recruitment to antigen-containing compartments, VTI1B appears dispensable for antigen processing functions, at least in the experimental systems examined.
Researchers face several technical challenges when studying endogenous VTI1B. Based on published methodologies, the following approaches have proven effective:
| Technique | Application | Advantages | Limitations |
|---|---|---|---|
| Antibody Detection | Western blot | Can detect endogenous protein | High background in immunofluorescence |
| GFP-VTI1B Transfection | Localization studies | Real-time monitoring, bright signal | Potential overexpression artifacts |
| Knockout/Knockdown | Functional analysis | Complete elimination of protein | Potential compensatory mechanisms |
| Colocalization Analysis | Compartment identification | Establishes subcellular location | Requires multiple validated markers |
| Bead/Surface Activation | Immune synapse studies | Quantifiable recruitment | In vitro approximation of in vivo process |
When designing experiments, researchers should validate antibodies using positive controls such as GFP-VTI1B transfected cells . For localization studies, comparing results from multiple detection methods is recommended.
Published research demonstrates effective methods for quantifying VTI1B polarization during immune synapse formation:
Distance measurement: Calculate the distance from the VTI1B endosomal compartment to the center of the activating bead or surface
Polarization index: Compare mean fluorescence intensities of VTI1B between the contact site and the distal pole of the cell
Colocalization analysis: Measure overlap with specific markers (F-actin, BCR, Rab proteins) at the immune synapse interface
Researchers should include appropriate controls (uncoated beads or fibronectin-coated surfaces) and collect data from multiple independent experiments to ensure statistical validity .
Based on current research approaches, several experimental systems can be employed:
Cell lines: Human B cell lines like Raji provide a consistent system for studying endogenous VTI1B
Primary cells: While challenging to obtain, primary human B cells would offer the most physiologically relevant system
Transfection models: GFP-VTI1B transfection in appropriate cell lines allows dynamic visualization
Knockout models: CRISPR/Cas9 technology can generate VTI1B-deficient human cell lines
In vitro activation systems: Anti-IgM coated beads or coverslips effectively mimic immune synapse formation
When selecting a model system, researchers should consider the specific research question, technical feasibility, and physiological relevance of the chosen system.
The paradoxical observation that VTI1B localizes to BCR activation sites yet appears functionally dispensable presents an interpretive challenge. When analyzing such data, researchers should consider:
Functional redundancy: The loss of VTI1B function may be compensated by its homologue VTI1A or other SNARE proteins
Condition-specific requirements: VTI1B may be essential under specific physiological conditions not captured in standard laboratory experiments
Subtle phenotypes: The absence of gross defects does not preclude minor functional alterations that require specialized detection methods
Regulatory rather than essential roles: VTI1B may optimize rather than enable specific cellular processes
Technical limitations: Current methodologies might not capture the true functional contribution of VTI1B
A comprehensive approach would involve simultaneous manipulation of multiple redundant components while examining a broad range of cellular functions under diverse conditions.
When interpreting VTI1B localization studies, researchers should consider several methodological factors:
Overexpression artifacts: GFP-VTI1B transfection may alter localization patterns compared to endogenous protein
Dynamic versus static analysis: Fixed-cell imaging may miss transient localization events visible in live-cell studies
Resolution limitations: Standard confocal microscopy may not resolve distinct membrane subdomains
Marker selection: Colocalization depends on the specific markers chosen (Rab6, Rab7, Rab11, etc.)
Activation conditions: Different modes of BCR activation (soluble vs. surface-bound antigen) may affect VTI1B dynamics
Researchers should employ complementary approaches and appropriate controls to ensure robust interpretation of localization data.
VTI1B is a v-SNARE (vesicle SNARE) protein that interacts with t-SNAREs (target SNAREs) on the target membrane. These interactions are critical for the specificity of vesicle trafficking and the promotion of lipid bilayer fusion . The protein contains a C-terminal transmembrane domain and two predicted coiled-coil regions . The human VTI1B protein is composed of 232 amino acids .
The primary function of VTI1B is to mediate vesicle transport pathways. This involves the transport of vesicles from the Golgi apparatus to the endosomes and lysosomes . VTI1B is also implicated in the secretion of cytokines associated with cellular senescence . The protein is expressed in all human tissues, indicating its fundamental role in cellular processes .
Mutations or dysregulation of VTI1B can have significant implications for cellular function. For instance, disruptions in VTI1B interactions can lead to improper vesicle trafficking, which may contribute to various diseases . The protein’s role in cytokine secretion also suggests a potential link to inflammatory conditions and cellular aging .
Research on VTI1B has provided insights into the molecular mechanisms of vesicle transport and membrane fusion. The protein’s interactions with clathrin-coated vesicles and its role in post-Golgi trafficking are areas of active investigation . Understanding these processes can inform the development of therapeutic strategies for diseases related to vesicle transport dysfunction.